1. Home
  2. Pharma & Healthcare
  3. Global Artificial Blood Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Global Artificial Blood Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publication Month: Feb 2020 | No. of Pages: 104 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

Market Overview
The global Artificial Blood market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.1% in the forecast period of 2020 to 2025 and will expected to reach USD 4372.1 million by 2025, from USD 2867.2 million in 2019.

The Artificial Blood market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Artificial Blood market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Artificial Blood market has been segmented into:
Human Blood
Synthetic Blood
Animal Blood

By Application, Artificial Blood has been segmented into:
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Artificial Blood market presented in the report. This section sheds light on the sales growth of different regional and country-level Artificial Blood markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Artificial Blood market.

The report offers in-depth assessment of the growth and other aspects of the Artificial Blood market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Artificial Blood Market Share Analysis
Artificial Blood competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Artificial Blood sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Artificial Blood sales, revenue and market share for each player covered in this report.

The major players covered in Artificial Blood are:
Dextro-Sang Corporation
Nuvox Pharma
Northfield Laboratories
BioPure Corporation
FluorO2 Therapeutics
Sangart
HemoBioTech
Dentritech
Baxter International
Alpha Therapeutic Corporation

Table of Contents

1 Artificial Blood Market Overview
1.1 Product Overview and Scope of Artificial Blood
1.2 Classification of Artificial Blood by Type
1.2.1 Global Artificial Blood Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Artificial Blood Revenue Market Share by Type in 2019
1.2.3 Human Blood
1.2.4 Synthetic Blood
1.2.5 Animal Blood
1.3 Global Artificial Blood Market by Application
1.3.1 Overview: Global Artificial Blood Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hemoglobin-Based Oxygen Carriers (HBOCs)
1.3.3 Perflurocarbon Emulsions (PFCEs)
1.4 Global Artificial Blood Market by Regions
1.4.1 Global Artificial Blood Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Artificial Blood (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Artificial Blood Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Artificial Blood Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Artificial Blood Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Artificial Blood Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Artificial Blood Status and Prospect (2015-2025)
2 Company Profiles
2.1 Dextro-Sang Corporation
2.1.1 Dextro-Sang Corporation Details
2.1.2 Dextro-Sang Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Dextro-Sang Corporation SWOT Analysis
2.1.4 Dextro-Sang Corporation Product and Services
2.1.5 Dextro-Sang Corporation Artificial Blood Revenue, Gross Margin and Market Share (2018-2019)
2.2 Nuvox Pharma
2.2.1 Nuvox Pharma Details
2.2.2 Nuvox Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Nuvox Pharma SWOT Analysis
2.2.4 Nuvox Pharma Product and Services
2.2.5 Nuvox Pharma Artificial Blood Revenue, Gross Margin and Market Share (2018-2019)
2.3 Northfield Laboratories
2.3.1 Northfield Laboratories Details
2.3.2 Northfield Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Northfield Laboratories SWOT Analysis
2.3.4 Northfield Laboratories Product and Services
2.3.5 Northfield Laboratories Artificial Blood Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioPure Corporation
2.4.1 BioPure Corporation Details
2.4.2 BioPure Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioPure Corporation SWOT Analysis
2.4.4 BioPure Corporation Product and Services
2.4.5 BioPure Corporation Artificial Blood Revenue, Gross Margin and Market Share (2018-2019)
2.5 FluorO2 Therapeutics
2.5.1 FluorO2 Therapeutics Details
2.5.2 FluorO2 Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 FluorO2 Therapeutics SWOT Analysis
2.5.4 FluorO2 Therapeutics Product and Services
2.5.5 FluorO2 Therapeutics Artificial Blood Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sangart
2.6.1 Sangart Details
2.6.2 Sangart Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sangart SWOT Analysis
2.6.4 Sangart Product and Services
2.6.5 Sangart Artificial Blood Revenue, Gross Margin and Market Share (2018-2019)
2.7 HemoBioTech
2.7.1 HemoBioTech Details
2.7.2 HemoBioTech Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 HemoBioTech SWOT Analysis
2.7.4 HemoBioTech Product and Services
2.7.5 HemoBioTech Artificial Blood Revenue, Gross Margin and Market Share (2018-2019)
2.8 Dentritech
2.8.1 Dentritech Details
2.8.2 Dentritech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Dentritech SWOT Analysis
2.8.4 Dentritech Product and Services
2.8.5 Dentritech Artificial Blood Revenue, Gross Margin and Market Share (2018-2019)
2.9 Baxter International
2.9.1 Baxter International Details
2.9.2 Baxter International Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Baxter International SWOT Analysis
2.9.4 Baxter International Product and Services
2.9.5 Baxter International Artificial Blood Revenue, Gross Margin and Market Share (2018-2019)
2.10 Alpha Therapeutic Corporation
2.10.1 Alpha Therapeutic Corporation Details
2.10.2 Alpha Therapeutic Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Alpha Therapeutic Corporation SWOT Analysis
2.10.4 Alpha Therapeutic Corporation Product and Services
2.10.5 Alpha Therapeutic Corporation Artificial Blood Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Artificial Blood Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Artificial Blood Players Market Share
3.2.2 Top 10 Artificial Blood Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Artificial Blood Revenue and Market Share by Regions
4.2 North America Artificial Blood Revenue and Growth Rate (2015-2020)
4.3 Europe Artificial Blood Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Artificial Blood Revenue and Growth Rate (2015-2020)
4.5 South America Artificial Blood Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Artificial Blood Revenue and Growth Rate (2015-2020)
5 North America Artificial Blood Revenue by Countries
5.1 North America Artificial Blood Revenue by Countries (2015-2020)
5.2 USA Artificial Blood Revenue and Growth Rate (2015-2020)
5.3 Canada Artificial Blood Revenue and Growth Rate (2015-2020)
5.4 Mexico Artificial Blood Revenue and Growth Rate (2015-2020)
6 Europe Artificial Blood Revenue by Countries
6.1 Europe Artificial Blood Revenue by Countries (2015-2020)
6.2 Germany Artificial Blood Revenue and Growth Rate (2015-2020)
6.3 UK Artificial Blood Revenue and Growth Rate (2015-2020)
6.4 France Artificial Blood Revenue and Growth Rate (2015-2020)
6.5 Russia Artificial Blood Revenue and Growth Rate (2015-2020)
6.6 Italy Artificial Blood Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Artificial Blood Revenue by Countries
7.1 Asia-Pacific Artificial Blood Revenue by Countries (2015-2020)
7.2 China Artificial Blood Revenue and Growth Rate (2015-2020)
7.3 Japan Artificial Blood Revenue and Growth Rate (2015-2020)
7.4 Korea Artificial Blood Revenue and Growth Rate (2015-2020)
7.5 India Artificial Blood Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Artificial Blood Revenue and Growth Rate (2015-2020)
8 South America Artificial Blood Revenue by Countries
8.1 South America Artificial Blood Revenue by Countries (2015-2020)
8.2 Brazil Artificial Blood Revenue and Growth Rate (2015-2020)
8.3 Argentina Artificial Blood Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Artificial Blood by Countries
9.1 Middle East & Africa Artificial Blood Revenue by Countries (2015-2020)
9.2 Saudi Arabia Artificial Blood Revenue and Growth Rate (2015-2020)
9.3 UAE Artificial Blood Revenue and Growth Rate (2015-2020)
9.4 Egypt Artificial Blood Revenue and Growth Rate (2015-2020)
9.5 South Africa Artificial Blood Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Artificial Blood Revenue and Market Share by Type (2015-2020)
10.2 Global Artificial Blood Market Forecast by Type (2019-2024)
10.3 Human Blood Revenue Growth Rate (2015-2025)
10.4 Synthetic Blood Revenue Growth Rate (2015-2025)
10.5 Animal Blood Revenue Growth Rate (2015-2025)
11 Global Artificial Blood Market Segment by Application
11.1 Global Artificial Blood Revenue Market Share by Application (2015-2020)
11.2 Artificial Blood Market Forecast by Application (2019-2024)
11.3 Hemoglobin-Based Oxygen Carriers (HBOCs) Revenue Growth (2015-2020)
11.4 Perflurocarbon Emulsions (PFCEs) Revenue Growth (2015-2020)
12 Global Artificial Blood Market Size Forecast (2021-2025)
12.1 Global Artificial Blood Market Size Forecast (2021-2025)
12.2 Global Artificial Blood Market Forecast by Regions (2021-2025)
12.3 North America Artificial Blood Revenue Market Forecast (2021-2025)
12.4 Europe Artificial Blood Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Artificial Blood Revenue Market Forecast (2021-2025)
12.6 South America Artificial Blood Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Artificial Blood Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

Tables and Figures

List of Tables

Table 1. Global Artificial Blood Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Artificial Blood by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Artificial Blood Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Artificial Blood Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Dextro-Sang Corporation Corporate Information, Location and Competitors
Table 6. Dextro-Sang Corporation Artificial Blood Major Business
Table 7. Dextro-Sang Corporation Artificial Blood Total Revenue (USD Million) (2017-2018)
Table 8. Dextro-Sang Corporation SWOT Analysis
Table 9. Dextro-Sang Corporation Artificial Blood Product and Solutions
Table 10. Dextro-Sang Corporation Artificial Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Nuvox Pharma Corporate Information, Location and Competitors
Table 12. Nuvox Pharma Artificial Blood Major Business
Table 13. Nuvox Pharma Artificial Blood Total Revenue (USD Million) (2018-2019)
Table 14. Nuvox Pharma SWOT Analysis
Table 15. Nuvox Pharma Artificial Blood Product and Solutions
Table 16. Nuvox Pharma Artificial Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Northfield Laboratories Corporate Information, Location and Competitors
Table 18. Northfield Laboratories Artificial Blood Major Business
Table 19. Northfield Laboratories Artificial Blood Total Revenue (USD Million) (2017-2018)
Table 20. Northfield Laboratories SWOT Analysis
Table 21. Northfield Laboratories Artificial Blood Product and Solutions
Table 22. Northfield Laboratories Artificial Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. BioPure Corporation Corporate Information, Location and Competitors
Table 24. BioPure Corporation Artificial Blood Major Business
Table 25. BioPure Corporation Artificial Blood Total Revenue (USD Million) (2017-2018)
Table 26. BioPure Corporation SWOT Analysis
Table 27. BioPure Corporation Artificial Blood Product and Solutions
Table 28. BioPure Corporation Artificial Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. FluorO2 Therapeutics Corporate Information, Location and Competitors
Table 30. FluorO2 Therapeutics Artificial Blood Major Business
Table 31. FluorO2 Therapeutics Artificial Blood Total Revenue (USD Million) (2017-2018)
Table 32. FluorO2 Therapeutics SWOT Analysis
Table 33. FluorO2 Therapeutics Artificial Blood Product and Solutions
Table 34. FluorO2 Therapeutics Artificial Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sangart Corporate Information, Location and Competitors
Table 36. Sangart Artificial Blood Major Business
Table 37. Sangart Artificial Blood Total Revenue (USD Million) (2017-2018)
Table 38. Sangart SWOT Analysis
Table 39. Sangart Artificial Blood Product and Solutions
Table 40. Sangart Artificial Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. HemoBioTech Corporate Information, Location and Competitors
Table 42. HemoBioTech Artificial Blood Major Business
Table 43. HemoBioTech Artificial Blood Total Revenue (USD Million) (2017-2018)
Table 44. HemoBioTech SWOT Analysis
Table 45. HemoBioTech Artificial Blood Product and Solutions
Table 46. HemoBioTech Artificial Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Dentritech Corporate Information, Location and Competitors
Table 48. Dentritech Artificial Blood Major Business
Table 49. Dentritech Artificial Blood Total Revenue (USD Million) (2017-2018)
Table 50. Dentritech SWOT Analysis
Table 51. Dentritech Artificial Blood Product and Solutions
Table 52. Dentritech Artificial Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Baxter International Corporate Information, Location and Competitors
Table 54. Baxter International Artificial Blood Major Business
Table 55. Baxter International Artificial Blood Total Revenue (USD Million) (2017-2018)
Table 56. Baxter International SWOT Analysis
Table 57. Baxter International Artificial Blood Product and Solutions
Table 58. Baxter International Artificial Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Alpha Therapeutic Corporation Corporate Information, Location and Competitors
Table 60. Alpha Therapeutic Corporation Artificial Blood Major Business
Table 61. Alpha Therapeutic Corporation Artificial Blood Total Revenue (USD Million) (2017-2018)
Table 62. Alpha Therapeutic Corporation SWOT Analysis
Table 63. Alpha Therapeutic Corporation Artificial Blood Product and Solutions
Table 64. Alpha Therapeutic Corporation Artificial Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Artificial Blood Revenue (Million USD) by Players (2015-2020)
Table 66. Global Artificial Blood Revenue Share by Players (2015-2020)
Table 67. Global Artificial Blood Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Artificial Blood Revenue Market Share by Regions (2015-2020)
Table 69. North America Artificial Blood Revenue by Countries (2015-2020)
Table 70. North America Artificial Blood Revenue Market Share by Countries (2015-2020)
Table 71. Europe Artificial Blood Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Artificial Blood Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Artificial Blood Revenue by Countries (2015-2020)
Table 74. South America Artificial Blood Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Artificial Blood Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Artificial Blood Revenue Market Share by Countries (2015-2020)
Table 77. Global Artificial Blood Revenue (Million USD) by Type (2015-2020)
Table 78. Global Artificial Blood Revenue Share by Type (2015-2020)
Table 79. Global Artificial Blood Revenue Forecast by Type (2021-2025)
Table 80. Global Artificial Blood Revenue by Application (2015-2020)
Table 81. Global Artificial Blood Revenue Share by Application (2015-2020)
Table 82. Global Artificial Blood Revenue Forecast by Application (2021-2025)
Table 83. Global Artificial Blood Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Artificial Blood Picture
Figure 2. Global Artificial Blood Revenue Market Share by Type in 2019
Figure 3. Human Blood Picture
Figure 4. Synthetic Blood Picture
Figure 5. Animal Blood Picture
Figure 6. Artificial Blood Revenue Market Share by Application in 2019
Figure 7. Hemoglobin-Based Oxygen Carriers (HBOCs) Picture
Figure 8. Perflurocarbon Emulsions (PFCEs) Picture
Figure 9. Global Artificial Blood Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Artificial Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Artificial Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Artificial Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Artificial Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Artificial Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Artificial Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Artificial Blood Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Artificial Blood Revenue Market Share in 2019
Figure 18. Global Top 10 Players Artificial Blood Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Artificial Blood Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Artificial Blood Revenue Market Share by Regions (2015-2020)
Figure 22. Global Artificial Blood Revenue Market Share by Regions in 2018
Figure 23. North America Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 24. Europe Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 26. South America Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 28. North America Artificial Blood Revenue Market Share by Countries (2015-2020)
Figure 29. North America Artificial Blood Revenue Market Share by Countries in 2019
Figure 30. USA Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 31. Canada Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 33. Europe Artificial Blood Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Artificial Blood Revenue Market Share by Countries in 2019
Figure 35. Germany Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 36. UK Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 37. France Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 38. Russia Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 39. Italy Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Artificial Blood Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Artificial Blood Revenue Market Share by Countries in 2019
Figure 42. China Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 43. Japan Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 44. Korea Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 45. India Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 47. South America Artificial Blood Revenue Market Share by Countries (2015-2020)
Figure 48. South America Artificial Blood Revenue Market Share by Countries in 2019
Figure 49. Brazil Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Artificial Blood Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Artificial Blood Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 54. UAE Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Artificial Blood Revenue and Growth Rate (2015-2020)
Figure 57. Global Artificial Blood Revenue Share by Type (2015-2020)
Figure 58. Global Artificial Blood Revenue Share by Type in 2019
Figure 59. Global Artificial Blood Market Share Forecast by Type (2021-2025)
Figure 60. Global Human Blood Revenue Growth Rate (2015-2020)
Figure 61. Global Synthetic Blood Revenue Growth Rate (2015-2020)
Figure 62. Global Animal Blood Revenue Growth Rate (2015-2020)
Figure 63. Global Artificial Blood Revenue Share by Application (2015-2020)
Figure 64. Global Artificial Blood Revenue Share by Application in 2019
Figure 65. Global Artificial Blood Market Share Forecast by Application (2021-2025)
Figure 66. Global Hemoglobin-Based Oxygen Carriers (HBOCs) Revenue Growth Rate (2015-2020)
Figure 67. Global Perflurocarbon Emulsions (PFCEs) Revenue Growth Rate (2015-2020)
Figure 68. Global Artificial Blood Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Artificial Blood Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Artificial Blood Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Artificial Blood Revenue Market Forecast (2021-2025)
Figure 72. Europe Artificial Blood Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Artificial Blood Revenue Market Forecast (2021-2025)
Figure 74. South America Artificial Blood Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Artificial Blood Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel




Companies Mentioned
Dextro-Sang Corporation
Nuvox Pharma
Northfield Laboratories
BioPure Corporation
FluorO2 Therapeutics
Sangart
HemoBioTech
Dentritech
Baxter International
Alpha Therapeutic Corporation

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets